Apr 29 |
Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024
|
Apr 15 |
BTIG Research Predicts Over 118% Rally for These 3 Stocks
|
Apr 15 |
Strength Seen in Theravance Bio (TBPH): Can Its 7.6% Jump Turn into More Strength?
|
Apr 10 |
Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024
|
Apr 3 |
Nektar (NKTR) Up 7.5% Since Last Earnings Report: Can It Continue?
|